Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Short-Term Debt issuances (2020 - 2025)

Bio Essence has reported Short-Term Debt issuances over the past 6 years, most recently at $4552.0 for Q2 2025.

  • Quarterly results put Short-Term Debt issuances at $4552.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $6966.0 (down 85.28% YoY), and the annual figure for FY2025 was $1531.0, up 116.23%.
  • Short-Term Debt issuances for Q2 2025 was $4552.0 at Bio Essence, up from $2414.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for BIOE hit a ceiling of $179140.0 in Q4 2021 and a floor of -$48100.0 in Q2 2023.
  • Median Short-Term Debt issuances over the past 5 years was $4552.0 (2025), compared with a mean of $9548.5.
  • Biggest five-year swings in Short-Term Debt issuances: crashed 1811.87% in 2021 and later skyrocketed 318.15% in 2022.
  • Bio Essence's Short-Term Debt issuances stood at $179140.0 in 2021, then tumbled by 95.97% to $7215.0 in 2022, then increased by 2.37% to $7386.0 in 2023, then plummeted by 227.76% to -$9436.0 in 2024, then soared by 148.24% to $4552.0 in 2025.
  • The last three reported values for Short-Term Debt issuances were $4552.0 (Q2 2025), $2414.0 (Q1 2025), and -$9436.0 (Q1 2024) per Business Quant data.